India Globalization Capital, Inc. (IGC)
| Market Cap | 71.96M |
| Revenue (ttm) | 391,000 |
| Net Income (ttm) | -8.72M |
| Shares Out | 47.91M |
| EPS (ttm) | -0.20 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 861,901 |
| Open | 1.45 |
| Previous Close | 1.47 |
| Day's Range | 1.41 - 1.46 |
| 52-Week Range | 1.10 - 4.65 |
| Beta | 4.62 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | Nov 15, 2021 |
About IGC
India Globalization Capital, Inc. purchases and resells physical infrastructure commodities. The company operates through two segments, Infrastructure Business, and Life Sciences. It buys and sells infrastructure commodities, such as steel, wooden doors, marble, and tiles; rents heavy construction equipment, including motor grader and rollers; and undertakes highway construction contracts. The company also develops cannabinoid-based products and therapies, such as Hyalolex for the treatment of patients from anxiety, agitation, dementia, depress...
Financial Performance
In 2020, IGC's revenue was $898,000, a decrease of -77.95% compared to the previous year's $4.07 million. Losses were -$8.81 million, 20.5% more than in 2019.
Financial StatementsNews
IGC Announces Results of its 2021 Annual Stockholders Meeting
POTOMAC, Md.--(BUSINESS WIRE)-- #Alzheimers--Voting on all matters as disclosed on the Def Proxy filed with the SEC on Sep 15'21 were passed at IGC's Annual Meeting of Shareholders on Oct 15'21.
IGC Completes its Phase 1 Clinical Trial on Alzheimer's Patients, Reports Safety and Tolerability
POTOMAC, Md.--(BUSINESS WIRE)-- #Alzheimers--IGC Completes its Phase 1 Clinical Trial on Alzheimer's Patients, Reports Safety and Tolerability.
IGC Reports Financial Results for the June 30, 2021, Quarter
BETHESDA, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC announces financial results for quarter ended Jun 30, 2021 & completion of Phase 1 clinical trial of IGC-AD1 to alleviate Alzheimer's symptoms.
An Unforgettable Week For Alzheimer's Treatment Stocks: Two Of Our Recent Top Names Spike On News Of Potentially Prom...
Screen capture via IGC's healthcare subsidiary Hyalolex. "Drops of Clarity" is their just-patented Alzheimer's treatment.
Why India Globalization Capital Shares Spiked Today
India Globalization Capital (AMEX:IGC) shares are trading higher after the company announced the issuance of a patent for the treatment of Alzheimer's disease using THC. The company was issued a patent...
India Globalization Capital Shares Skyrocket On Receiving Patent For THC Formula To Treat Alzheimer's Disease
India Globalization Capital, Inc. (AMEX: IGC) revealed Thursday that it has obtained a patent from the United States Patent and Trademark Office for the treatment of Alzheimer's disease. The patent (#11...
Highest Volume Penny Stocks to Watch Today? Check These 4 Out
Best high-volume penny stocks for your watchlist right now? Check these 4 out The post Highest Volume Penny Stocks to Watch Today?
IGC Stock: The Huge Cannabis Patent News That Has IGC Flying High
IGC stock is moving up in a huge way today. The company is finally earning its patent for the treatment of Alzheimer's disease with cannabis.
IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC
POTOMAC, Md.--(BUSINESS WIRE)--IGC Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC
Top Penny Stocks To Buy Now? 10 To Watch As AMC Volatility Continues
Which penny stocks are investors watching with AMC back in focus? The post Top Penny Stocks To Buy Now?
Pot Stocks in Focus: Cannabis-Based Pharmaceutical Trials
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week and look ahead to how the cannabis industry continues t...
IGC Completes the Final Cohort of Its Phase 1 Clinical Trial on Alzheimer's Patients
POTOMAC, Md.--(BUSINESS WIRE)-- #IGCAD1--IGC completed Final Cohort of Phase 1 clinical trial on its THC-based investigational new drug intended to alleviate symptoms of Alzheimer's disease.
IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Reports Financial Results for the Fiscal Year Ended March 31, 2021.
IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 2 of its Phase 1 Tetrahydrocannabinol (“THC”)-Based Investigational New Drug Clinical Trial on Alzheimer's Patients.
India Globalization Capital (IGC) Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Completes Cohort 1 of its Phase 1 THC-Based Clinical Trial on Alzheimer's Patients
IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC got patent (#10,933,082) x its cannabinoid composition & method x treating pain due to Psoriatic Arthritis, Fibromyalgia, Scleroderma & others.
Update On IGC's Phase 1 Clinical Trial on Alzheimer's Patients
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC completed administering 1st of 3 levels of dosing of IGC-AD1 on its FDA-approved THC-based phase 1 clinical trial on patients with Alzheimer's.
India Globalization Capital Nominates Mr. John E. Lynch to its Board of Directors
BETHESDA, Md.--(BUSINESS WIRE)-- #AD--IGC nominated Mr. Lynch as a Class A independent director for election at the Company's 2020 Annual Meeting of Stockholders, to be held on Jan 11 '21.
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer's Patients
POTOMAC, MD--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe dementia due...
IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzh...
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2020, which...
IGC's stock rallies again, after rocketing fourfold on record volume in the previous session
Shares of Inc. India Globalization Capital IGC, +300.37% surged 26% in premarket trading Thursday, to extend the fourfold rocket ride in the previous session, as they head for an open at the highest le...
India Globalization Capital More Than Doubles Revenue, Posts Q2 Net Loss of $1.32M
India Globalization Capital, Inc. (NYSE: IGC) reported Wednesday with second-quarter revenue of $1.8 million, up 125% from the same quarter in 2018, when it posted $810,000 in revenue.
India Globalization Capital Subsidiary Secures Hemp Cultivation, Harvesting License In Arizona
Holi Hemp, a subsidiary of India Globalization Capital, Inc. (NYSE: IGC), said Thursday that its application for the cultivation and harvesting of hemp was approved by Arizona’s Department of Agricultur...
A-Rated Stocks to Buy Under $10
These stocks to buy are low-priced, top quality choices for growth. Here's what you need to know about each.